Eterna Therapeutics
ERNA
#10525
Rank
C$8.29 M
Marketcap
C$0.28
Share price
-6.32%
Change (1 day)
-93.27%
Change (1 year)

Eterna Therapeutics (ERNA) Fails to deliver data

Key failure to deliver metrics for Eterna Therapeutics:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Eterna Therapeutics (ERNA) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Eterna Therapeutics (ERNA) - since 2022

Volume in USD (price x number of shares), data since 2022

Eterna Therapeutics (ERNA) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2025C$1.51 M98.32%
2024C$0.76 M88.02%
2023C$0.4 M-70.43%
2022C$1.37 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Sanofi
SNY
C$1.29 MC$70.46 M๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
C$23.64 MC$86.49 M๐Ÿ‡บ๐Ÿ‡ธ USA
Omeros Corporation
OMER
C$6.01 MC$19.99 M๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
C$3.32 MC$7.69 M๐Ÿ‡บ๐Ÿ‡ธ USA
Genetic Technologies
GENE
N/AC$0 M๐Ÿ‡ฆ๐Ÿ‡บ Australia
Teva Pharmaceutical Industries
TEVA
C$56.6 MC$88.67 M๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Bio-Techne
TECH
C$5.73 MC$24.33 M๐Ÿ‡บ๐Ÿ‡ธ USA